TARDBP and amyotrophic lateral sclerosis: Conversely, in an ALS/FTD model, Vaccaro et al. (2012a,b) showed that transgenic worms expressing either mutant or wild-type human TDP-43 and FUS differed in their response to aldicarb, with the mutants exhibiting hypersensitivity to paralysis.